Image Source: http://bio-meme.com
No we are not kidding here. Biomeme(http://bio-meme.com), Philadelphia based startup has already developed a platform that can transform your mobile(Both Apple:https://www.apple.com and Android Based:https://www.google.co.in/) into a lab for disease diagnostics and disease surveillance. Device answers long standing problem of field based diagnostics in a way, that neither of us could ever imagine. Dreamit ventures (http://www.dreamitventures.com)has already pumped in 1.3 million USD into the company, with confidence on platforms future application beyond health care.Device contain docking system for real time qPCR, an app to control mobile system & analyze results and lastly kits for sample preparation and pathogen identification. Device can be used by anyone with no prior experience, does not require expensive PCR equipments and to top it all performs to gold standard used by all the leading central labs.
Price of the device is likely to be very reasonable and as per Techcrunch(http://techcrunch.com
) it would be around USD 1000. LOP (Lab on phone) would address multiple facets of healthcare , agriculture, vector surveillance, veterinary medicine and environment testing.
With everything and anything in health care getting portable and miniaturized, lab miniaturization was never part of anybodies thought process. Device has a great potential to cater to current and future need in DNA diagnostics, but going by 23andme(https://www.23andme.com/
) past with FDA, it would be too soon to commit on how the device will be perceived by regulatory bodies.Company claims that they would sell the device outside US to generate cash for ramping their R&D before going big in US.
We strongly vouch for this breakthrough on every aspect and would call it a shear brilliance on face of innovation.
Source: Crunch Base and Biomeme Website
Key Words: #Diagnostics #23andMe #Apple #Dreamit Ventures #Google